Treatment satisfaction and response in patients with severe alopecia areata under treatment with diphenylcyclopropenone.

ABSTRACT:

Background and aims

Alopecia areata (AA) is an autoimmune disease of hair follicles. Treatments currently include topical and intralesional corticosteroids and contact immunotherapy; however, the overall prognosis is usually unfavorable. In severe AA, topical immunotherapy with diphenylcyclopropenone (DPCP) is preferred. Since its effectiveness is heterogeneous and there are several side effects, we decided to measure the patients' satisfaction using the "Version II of the Treatment Satisfaction Questionnaire for Medication," which investigates satisfaction with effectiveness, side effects, convenience, and global satisfaction.

Methods

We examined 100 patients under treatment with DPCP for treatment response, asked them to respond to the questionnaire, and calculated their o

SUBMITTER: Abedini R 

PROVIDER: S-EPMC9059174 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature